Effects	NNS
of	IN
antifibrotic	JJ
agents	NNS
on	IN
TGF-beta1	NN
,	,
CTGF	NN
and	CC
IFN-gamma	NN
expression	NN
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
deadly	JJ
disease	NN
,	,
largely	RB
unresponsive	JJ
to	TO
treatment	NN
with	IN
corticosteroids	NNS
and	CC
immunosuppressives	NNS
.	.

The	DT
aim	NN
of	IN
this	DT
randomized	VBN
,	,
prospective	JJ
,	,
open-label	JJ
study	NN
was	VBD
to	TO
characterize	VB
the	DT
molecular	JJ
effects	NNS
of	IN
IFN-gamma-1b	NN
and	CC
colchicine	NN
,	,
on	IN
biomarkers	NNS
expression	NN
associated	VBN
with	IN
fibrosis	NN
(	(
TGF-beta	NN
,	,
CTGF	NN
)	)
and	CC
immunomodulatory/antimicrobial	JJ
activity	NN
(	(
IFN-gamma	NN
)	)
,	,
in	IN
the	DT
lungs	NNS
of	IN
patients	NNS
with	IN
IPF	NN
.	.

Fourteen	CD
(	(
14	CD
)	)
patients	NNS
with	IN
an	DT
established	JJ
diagnosis	NN
of	IN
IPF	NN
received	VBD
either	CC
200	CD
microg	NN
of	IN
IFN-gamma-1b	NN
subcutaneously	RB
three	CD
times	NNS
per	IN
week	NN
,	,
or	CC
1	CD
mg	NN
of	IN
oral	JJ
colchicine	NN
per	IN
day	NN
,	,
for	IN
24	CD
months	NNS
.	.

Using	VBG
RT-PCR	NN
assay	NN
,	,
we	PRP
evaluated	VBD
the	DT
transcription	NN
levels	NNS
of	IN
transforming-growth-factor-beta1	NN
(	(
TGF-beta1	NN
)	)
,	,
connective-tissue	JJ
growth	NN
factor	NN
(	(
CTGF	NN
)	)
,	,
and	CC
interferon-gamma	NN
(	(
IFN-gamma	NN
)	)
genes	NNS
in	IN
lung	NN
tissue	NN
before	IN
and	CC
after	IN
treatment	NN
with	IN
IFN-gamma-1b	NN
or	CC
colchicine	NN
.	.

Marked	JJ
mRNA	NN
expression	NN
of	IN
TGF-beta1	NN
and	CC
CTGF	NN
,	,
but	CC
complete	JJ
lack	NN
of	IN
interferon-gamma	NN
was	VBD
detected	VBN
in	IN
fibrotic	JJ
lung	NN
tissue	NN
at	IN
entry	NN
.	.

After	IN
treatment	NN
,	,
both	DT
groups	NNS
exhibited	VBD
increased	VBN
expression	NN
of	IN
IFN-gamma	NN
gene	NN
at	IN
6	CD
months	NNS
that	WDT
was	VBD
sustained	VBN
at	IN
24	CD
months	NNS
.	.

The	DT
expression	NN
of	IN
CTGF	NN
and	CC
TGF-beta1	NN
remained	VBD
almost	RB
stable	JJ
before	IN
and	CC
after	IN
treatment	NN
,	,
in	IN
the	DT
IFN-gamma-1b	JJ
group	NN
,	,
while	IN
TGF-beta1	NN
was	VBD
statistically	RB
decreased	VBN
after	IN
therapy	NN
,	,
in	IN
the	DT
colchicine	NN
group	NN
(	(
p	NN
=	JJ
0.0002	CD
)	)
.	.

Significant	JJ
difference	NN
in	IN
DLCO	NNP
(	(
%	NN
pred	VBN
)	)
,	,
was	VBD
found	VBN
between	IN
the	DT
two	CD
treatment	NN
groups	NNS
in	IN
favor	NN
of	IN
IFN-gamma-1b	NN
group	NN
(	(
p	NN
=	JJ
0.04	CD
)	)
.	.

In	IN
addition	NN
,	,
the	DT
IFN-gamma-1b	JJ
group	NN
showed	VBD
stability	NN
in	IN
arterial	JJ
PO2	NN
while	IN
the	DT
colchicine	NN
group	NN
significantly	RB
deteriorated	JJ
(	(
p	NN
=	JJ
0.02	CD
)	)
.	.

In	IN
conclusion	NN
,	,
we	PRP
report	VBP
the	DT
effect	NN
of	IN
antifibrotic	JJ
agents	NNS
(	(
IFN-gamma-1b	NN
and	CC
colchicine	NN
)	)
in	IN
TGF-beta	NN
,	,
CTGF	NN
,	,
and	CC
endogenous	JJ
IFN-gamma	NN
gene	NN
expression	NN
,	,
in	IN
human	JJ
fibrosis	NN
.	.

However	RB
,	,
extended	JJ
studies	NNS
are	VBP
needed	VBN
to	TO
verify	VB
the	DT
pathophysiological	JJ
consequences	NNS
of	IN
these	DT
findings	NNS
.	.

